353 related articles for article (PubMed ID: 7955037)
1. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
Randerath K; Moorthy B; Mabon N; Sriram P
Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
[TBL] [Abstract][Full Text] [Related]
2. Pentachlorophenol enhances 9-hydroxybenzo [a] pyrene-induced hepatic DNA adduct formation in vivo and inhibits microsomal epoxide hydrolase and glutathione S-transferase activities in vitro: likely inhibition of epoxide detoxication by pentachlorophenol.
Moorthy B; Randerath K
Arch Toxicol; 1996; 70(11):696-703. PubMed ID: 8896715
[TBL] [Abstract][Full Text] [Related]
3. Strong intensification of mouse hepatic tamoxifen DNA adduct formation by pretreatment with the sulfotransferase inhibitor and ubiquitous environmental pollutant pentachlorophenol.
Randerath K; Bi J; Mabon N; Sriram P; Moorthy B
Carcinogenesis; 1994 May; 15(5):797-800. PubMed ID: 8200078
[TBL] [Abstract][Full Text] [Related]
4. Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen.
Pathak DN; Pongracz K; Bodell WJ
Carcinogenesis; 1995 Jan; 16(1):11-5. PubMed ID: 7834794
[TBL] [Abstract][Full Text] [Related]
5. Evidence from 32P-postlabeling and the use of pentachlorophenol for a novel metabolic activation pathway of diethylstilbestrol and its dimethyl ether in mouse live: likely alpha-hydroxylation of ethyl group(s) followed by sulfate conjugation.
Moorthy B; Liehr J; Randerath E; Randerath K
Carcinogenesis; 1995 Nov; 16(11):2643-8. PubMed ID: 7586180
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
[TBL] [Abstract][Full Text] [Related]
8. DNA damage induced in mouse tissues by organic wood preserving waste extracts as assayed by 32P-postlabeling.
Randerath E; Zhou GD; Donnelly KC; Safe SH; Randerath K
Arch Toxicol; 1996; 70(11):683-95. PubMed ID: 8896714
[TBL] [Abstract][Full Text] [Related]
9. Activation of 4-hydroxytamoxifen and the tamoxifen derivative metabolite E by uterine peroxidase to form DNA adducts: comparison with DNA adducts formed in the uterus of Sprague-Dawley rats treated with tamoxifen.
Pathak DN; Pongracz K; Bodell WJ
Carcinogenesis; 1996 Sep; 17(9):1785-90. PubMed ID: 8824496
[TBL] [Abstract][Full Text] [Related]
10. Effects of cytochrome P450 inducers on tamoxifen genotoxicity in female mice in vivo.
Moorthy B; Sriram P; Randerath E; Randerath K
Biochem Pharmacol; 1997 Mar; 53(5):663-9. PubMed ID: 9113085
[TBL] [Abstract][Full Text] [Related]
11. The effect of pentachlorophenol on DNA adduct formation in p53 wild-type and knockout mice exposed to benzo[a]pyrene.
Ress NB; Donnelly KC; George SE
Cancer Lett; 2002 Apr; 178(1):11-7. PubMed ID: 11849736
[TBL] [Abstract][Full Text] [Related]
12. Initiation of hepatocarcinogenesis in infant male B6C3F1 mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetylaminofluorene depends primarily on metabolism to N-sulfooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adducts.
Lai CC; Miller EC; Miller JA; Liem A
Carcinogenesis; 1987 Mar; 8(3):471-8. PubMed ID: 3815742
[TBL] [Abstract][Full Text] [Related]
13. In vivo formation of DNA-adducts in mouse skin DNA by tamoxifen.
Cai Q; Wei H
Cancer Lett; 1995 Jun; 92(2):187-92. PubMed ID: 7600530
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen.
Divi RL; Dragan YP; Pitot HC; Poirier MC
Carcinogenesis; 2001 Oct; 22(10):1693-9. PubMed ID: 11577011
[TBL] [Abstract][Full Text] [Related]
15. Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers.
Kim SY; Laxmi YR; Suzuki N; Ogura K; Watabe T; Duffel MW; Shibutani S
Drug Metab Dispos; 2005 Nov; 33(11):1673-8. PubMed ID: 16099924
[TBL] [Abstract][Full Text] [Related]
16. Identification of hepatic tamoxifen-DNA adducts in mice: alpha-(N(2)-deoxyguanosinyl)tamoxifen and alpha-(N(2)-deoxyguanosinyl)tamoxifen N-oxide.
Umemoto A; Monden Y; Suwa M; Kanno Y; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S; Komaki K
Carcinogenesis; 2000 Sep; 21(9):1737-44. PubMed ID: 10964106
[TBL] [Abstract][Full Text] [Related]
17. Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days.
Schild LJ; Divi RL; Beland FA; Churchwell MI; Doerge DR; Gamboa da Costa G; Marques MM; Poirier MC
Cancer Res; 2003 Sep; 63(18):5999-6003. PubMed ID: 14522927
[TBL] [Abstract][Full Text] [Related]
18. 32P-postlabeling analysis of DNA adduction in mice by synthetic metabolites of the environmental carcinogen, 7H-dibenzo[c,g]carbazole: chromatographic evidence for 3-hydroxy-7H-dibenzo[c,g]carbazole being a proximate genotoxicant in liver but not skin.
Schurdak ME; Stong DB; Warshawsky D; Randerath K
Carcinogenesis; 1987 Apr; 8(4):591-7. PubMed ID: 3829321
[TBL] [Abstract][Full Text] [Related]
19. Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts.
Boocock DJ; Maggs JL; Brown K; White IN; Park BK
Carcinogenesis; 2000 Oct; 21(10):1851-8. PubMed ID: 11023543
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
